Cholinergic Receptor, Nicotinic, Beta 2 (CHRNb2) ELISA kit

Basic informations

  • Size: 1 kit/96-well plate
  • Catalog number: SEB513Hu
  • Price: 778.00EUR
Cholinergic Receptor, Nicotinic, Beta 2 (CHRNb2) ELISA kit

Short description of the assay

Sandwich ELISA for determination of the concentration of Cholinergic Receptor, Nicotinic, Beta 2

Antigen concentration that can be measured

0.156-10ng per ml

Long name

ELISA kit for Cholinergic Receptor, Nicotinic, Beta 2 (CHRNb2)

Target antigen

Cholinergic Receptor, Nicotinic, Beta 2

Storage conditions

The reagents included in the kit for detection of the target antigen CHRNb2 should be stored according to the instructions presented in the technical file. All procedures described in the protocol should be followed striclty to obtain correct and reproducible results.

Tips

The Cholinergic Receptor, Nicotinic, Beta 2 (CHRNb2) ELISA kit is intended to be used for research purposes only and it is not applicable to in vitro diagnostic procedures.

Synonyms

CHR-NB2; CHRN-B2; EFNL3; NAChRB2; N-AChR-B2; N-AChRB2; Neuronal Acetylcholine Receptor Beta 2

Experimental field

Signal transduction;Neuro science;Developmental science;Bone metabolism;

Properties

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays

Test

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Description

The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.